ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Respiratory Virus Vaccines Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-6I8701
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Respiratory Virus Vaccines Market Insights Forecast to 2028
BUY CHAPTERS

Global Respiratory Virus Vaccines Market Research Report 2025

Code: QYRE-Auto-6I8701
Report
July 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Limited
Sanofi
Astrazeneca plc
Merck& Co. Inc
GlaxoSmithKline PLC
Serum Institute of India Pvt. Ltd
Bharat Biotech
Sinovac Biotech Ltd.

Respiratory Virus Vaccines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Respiratory Virus Vaccines Market

Respiratory Virus Vaccines Market

The global market for Respiratory Virus Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Respiratory virus vaccines are used to prevent viruses from harming the human body. There are a variety of vaccines against pancreatitis, rubella, measles, influenza, coronavirus and other viruses. The components of the vaccine are also differentiated according to age.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Respiratory Virus Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Virus Vaccines.
The Respiratory Virus Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Respiratory Virus Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Virus Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Respiratory Virus Vaccines Market Report

Report Metric Details
Report Name Respiratory Virus Vaccines Market
CAGR 5%
Segment by Type
  • Inactivated Vaccines
  • Live-attenuated Vaccines
  • Recombinant Vaccines
Segment by Application
  • Physician's Office
  • Hospitals
  • Clinics
  • Pharmacies/Stores
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL Limited, Sanofi, AstraZeneca, Merck & Co., Inc., GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Bharat Biotech, Sinovac Biotech Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Respiratory Virus Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Respiratory Virus Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Respiratory Virus Vaccines Market report?

Ans: The main players in the Respiratory Virus Vaccines Market are CSL Limited, Sanofi, AstraZeneca, Merck & Co., Inc., GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Bharat Biotech, Sinovac Biotech Ltd.

What are the Application segmentation covered in the Respiratory Virus Vaccines Market report?

Ans: The Applications covered in the Respiratory Virus Vaccines Market report are Physician's Office, Hospitals, Clinics, Pharmacies/Stores

What are the Type segmentation covered in the Respiratory Virus Vaccines Market report?

Ans: The Types covered in the Respiratory Virus Vaccines Market report are Inactivated Vaccines, Live-attenuated Vaccines, Recombinant Vaccines

1 Respiratory Virus Vaccines Market Overview
1.1 Product Definition
1.2 Respiratory Virus Vaccines by Type
1.2.1 Global Respiratory Virus Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Inactivated Vaccines
1.2.3 Live-attenuated Vaccines
1.2.4 Recombinant Vaccines
1.3 Respiratory Virus Vaccines by Application
1.3.1 Global Respiratory Virus Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Physician's Office
1.3.3 Hospitals
1.3.4 Clinics
1.3.5 Pharmacies/Stores
1.4 Global Respiratory Virus Vaccines Market Size Estimates and Forecasts
1.4.1 Global Respiratory Virus Vaccines Revenue 2020-2031
1.4.2 Global Respiratory Virus Vaccines Sales 2020-2031
1.4.3 Global Respiratory Virus Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Respiratory Virus Vaccines Market Competition by Manufacturers
2.1 Global Respiratory Virus Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Respiratory Virus Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Respiratory Virus Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Respiratory Virus Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Respiratory Virus Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Respiratory Virus Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Respiratory Virus Vaccines, Date of Enter into This Industry
2.8 Global Respiratory Virus Vaccines Market Competitive Situation and Trends
2.8.1 Global Respiratory Virus Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Respiratory Virus Vaccines Players Market Share by Revenue
2.8.3 Global Respiratory Virus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Respiratory Virus Vaccines Market Scenario by Region
3.1 Global Respiratory Virus Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Respiratory Virus Vaccines Sales by Region: 2020-2031
3.2.1 Global Respiratory Virus Vaccines Sales by Region: 2020-2025
3.2.2 Global Respiratory Virus Vaccines Sales by Region: 2026-2031
3.3 Global Respiratory Virus Vaccines Revenue by Region: 2020-2031
3.3.1 Global Respiratory Virus Vaccines Revenue by Region: 2020-2025
3.3.2 Global Respiratory Virus Vaccines Revenue by Region: 2026-2031
3.4 North America Respiratory Virus Vaccines Market Facts & Figures by Country
3.4.1 North America Respiratory Virus Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Respiratory Virus Vaccines Sales by Country (2020-2031)
3.4.3 North America Respiratory Virus Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Respiratory Virus Vaccines Market Facts & Figures by Country
3.5.1 Europe Respiratory Virus Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Respiratory Virus Vaccines Sales by Country (2020-2031)
3.5.3 Europe Respiratory Virus Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Respiratory Virus Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Respiratory Virus Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Respiratory Virus Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Respiratory Virus Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Respiratory Virus Vaccines Market Facts & Figures by Country
3.7.1 Latin America Respiratory Virus Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Respiratory Virus Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Respiratory Virus Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Respiratory Virus Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Respiratory Virus Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Respiratory Virus Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Respiratory Virus Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Respiratory Virus Vaccines Sales by Type (2020-2031)
4.1.1 Global Respiratory Virus Vaccines Sales by Type (2020-2025)
4.1.2 Global Respiratory Virus Vaccines Sales by Type (2026-2031)
4.1.3 Global Respiratory Virus Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Respiratory Virus Vaccines Revenue by Type (2020-2031)
4.2.1 Global Respiratory Virus Vaccines Revenue by Type (2020-2025)
4.2.2 Global Respiratory Virus Vaccines Revenue by Type (2026-2031)
4.2.3 Global Respiratory Virus Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Respiratory Virus Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Respiratory Virus Vaccines Sales by Application (2020-2031)
5.1.1 Global Respiratory Virus Vaccines Sales by Application (2020-2025)
5.1.2 Global Respiratory Virus Vaccines Sales by Application (2026-2031)
5.1.3 Global Respiratory Virus Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Respiratory Virus Vaccines Revenue by Application (2020-2031)
5.2.1 Global Respiratory Virus Vaccines Revenue by Application (2020-2025)
5.2.2 Global Respiratory Virus Vaccines Revenue by Application (2026-2031)
5.2.3 Global Respiratory Virus Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Respiratory Virus Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL Limited
6.1.1 CSL Limited Company Information
6.1.2 CSL Limited Description and Business Overview
6.1.3 CSL Limited Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Limited Respiratory Virus Vaccines Product Portfolio
6.1.5 CSL Limited Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Respiratory Virus Vaccines Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Respiratory Virus Vaccines Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Merck & Co., Inc.
6.4.1 Merck & Co., Inc. Company Information
6.4.2 Merck & Co., Inc. Description and Business Overview
6.4.3 Merck & Co., Inc. Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck & Co., Inc. Respiratory Virus Vaccines Product Portfolio
6.4.5 Merck & Co., Inc. Recent Developments/Updates
6.5 GlaxoSmithKline plc
6.5.1 GlaxoSmithKline plc Company Information
6.5.2 GlaxoSmithKline plc Description and Business Overview
6.5.3 GlaxoSmithKline plc Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GlaxoSmithKline plc Respiratory Virus Vaccines Product Portfolio
6.5.5 GlaxoSmithKline plc Recent Developments/Updates
6.6 Serum Institute of India Pvt. Ltd.
6.6.1 Serum Institute of India Pvt. Ltd. Company Information
6.6.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
6.6.3 Serum Institute of India Pvt. Ltd. Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Serum Institute of India Pvt. Ltd. Respiratory Virus Vaccines Product Portfolio
6.6.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
6.7 Bharat Biotech
6.7.1 Bharat Biotech Company Information
6.7.2 Bharat Biotech Description and Business Overview
6.7.3 Bharat Biotech Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bharat Biotech Respiratory Virus Vaccines Product Portfolio
6.7.5 Bharat Biotech Recent Developments/Updates
6.8 Sinovac Biotech Ltd.
6.8.1 Sinovac Biotech Ltd. Company Information
6.8.2 Sinovac Biotech Ltd. Description and Business Overview
6.8.3 Sinovac Biotech Ltd. Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sinovac Biotech Ltd. Respiratory Virus Vaccines Product Portfolio
6.8.5 Sinovac Biotech Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Respiratory Virus Vaccines Industry Chain Analysis
7.2 Respiratory Virus Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Respiratory Virus Vaccines Production Mode & Process Analysis
7.4 Respiratory Virus Vaccines Sales and Marketing
7.4.1 Respiratory Virus Vaccines Sales Channels
7.4.2 Respiratory Virus Vaccines Distributors
7.5 Respiratory Virus Vaccines Customer Analysis
8 Respiratory Virus Vaccines Market Dynamics
8.1 Respiratory Virus Vaccines Industry Trends
8.2 Respiratory Virus Vaccines Market Drivers
8.3 Respiratory Virus Vaccines Market Challenges
8.4 Respiratory Virus Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CSL Limited
Sanofi
Astrazeneca plc
Merck& Co. Inc
GlaxoSmithKline PLC
Serum Institute of India Pvt. Ltd
Bharat Biotech
Sinovac Biotech Ltd.
List of Tables
 Table 1. Global Respiratory Virus Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Respiratory Virus Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Respiratory Virus Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Respiratory Virus Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Respiratory Virus Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Respiratory Virus Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Respiratory Virus Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Respiratory Virus Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Respiratory Virus Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Respiratory Virus Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Respiratory Virus Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Respiratory Virus Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Respiratory Virus Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Virus Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Respiratory Virus Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Respiratory Virus Vaccines Sales by Region (2020-2025) & (K Units)
 Table 18. Global Respiratory Virus Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Respiratory Virus Vaccines Sales by Region (2026-2031) & (K Units)
 Table 20. Global Respiratory Virus Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Respiratory Virus Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Respiratory Virus Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Respiratory Virus Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Respiratory Virus Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Respiratory Virus Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Respiratory Virus Vaccines Sales by Country (2020-2025) & (K Units)
 Table 27. North America Respiratory Virus Vaccines Sales by Country (2026-2031) & (K Units)
 Table 28. North America Respiratory Virus Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Respiratory Virus Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Respiratory Virus Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Respiratory Virus Vaccines Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Respiratory Virus Vaccines Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Respiratory Virus Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Respiratory Virus Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Respiratory Virus Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Respiratory Virus Vaccines Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Respiratory Virus Vaccines Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Respiratory Virus Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Respiratory Virus Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Respiratory Virus Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Respiratory Virus Vaccines Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Respiratory Virus Vaccines Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Respiratory Virus Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Respiratory Virus Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Respiratory Virus Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Respiratory Virus Vaccines Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Respiratory Virus Vaccines Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Respiratory Virus Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Respiratory Virus Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Respiratory Virus Vaccines Sales (K Units) by Type (2020-2025)
 Table 51. Global Respiratory Virus Vaccines Sales (K Units) by Type (2026-2031)
 Table 52. Global Respiratory Virus Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Respiratory Virus Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Respiratory Virus Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Respiratory Virus Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Respiratory Virus Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Respiratory Virus Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Respiratory Virus Vaccines Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Respiratory Virus Vaccines Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Respiratory Virus Vaccines Sales (K Units) by Application (2020-2025)
 Table 61. Global Respiratory Virus Vaccines Sales (K Units) by Application (2026-2031)
 Table 62. Global Respiratory Virus Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Respiratory Virus Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Respiratory Virus Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Respiratory Virus Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Respiratory Virus Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Respiratory Virus Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Respiratory Virus Vaccines Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Respiratory Virus Vaccines Price (US$/Unit) by Application (2026-2031)
 Table 70. CSL Limited Company Information
 Table 71. CSL Limited Description and Business Overview
 Table 72. CSL Limited Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. CSL Limited Respiratory Virus Vaccines Product
 Table 74. CSL Limited Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi Respiratory Virus Vaccines Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. AstraZeneca Company Information
 Table 81. AstraZeneca Description and Business Overview
 Table 82. AstraZeneca Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. AstraZeneca Respiratory Virus Vaccines Product
 Table 84. AstraZeneca Recent Developments/Updates
 Table 85. Merck & Co., Inc. Company Information
 Table 86. Merck & Co., Inc. Description and Business Overview
 Table 87. Merck & Co., Inc. Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Merck & Co., Inc. Respiratory Virus Vaccines Product
 Table 89. Merck & Co., Inc. Recent Developments/Updates
 Table 90. GlaxoSmithKline plc Company Information
 Table 91. GlaxoSmithKline plc Description and Business Overview
 Table 92. GlaxoSmithKline plc Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. GlaxoSmithKline plc Respiratory Virus Vaccines Product
 Table 94. GlaxoSmithKline plc Recent Developments/Updates
 Table 95. Serum Institute of India Pvt. Ltd. Company Information
 Table 96. Serum Institute of India Pvt. Ltd. Description and Business Overview
 Table 97. Serum Institute of India Pvt. Ltd. Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Serum Institute of India Pvt. Ltd. Respiratory Virus Vaccines Product
 Table 99. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
 Table 100. Bharat Biotech Company Information
 Table 101. Bharat Biotech Description and Business Overview
 Table 102. Bharat Biotech Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bharat Biotech Respiratory Virus Vaccines Product
 Table 104. Bharat Biotech Recent Developments/Updates
 Table 105. Sinovac Biotech Ltd. Company Information
 Table 106. Sinovac Biotech Ltd. Description and Business Overview
 Table 107. Sinovac Biotech Ltd. Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sinovac Biotech Ltd. Respiratory Virus Vaccines Product
 Table 109. Sinovac Biotech Ltd. Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Respiratory Virus Vaccines Distributors List
 Table 113. Respiratory Virus Vaccines Customers List
 Table 114. Respiratory Virus Vaccines Market Trends
 Table 115. Respiratory Virus Vaccines Market Drivers
 Table 116. Respiratory Virus Vaccines Market Challenges
 Table 117. Respiratory Virus Vaccines Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Respiratory Virus Vaccines
 Figure 2. Global Respiratory Virus Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Respiratory Virus Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Inactivated Vaccines Product Picture
 Figure 5. Live-attenuated Vaccines Product Picture
 Figure 6. Recombinant Vaccines Product Picture
 Figure 7. Global Respiratory Virus Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Respiratory Virus Vaccines Market Share by Application: 2024 & 2031
 Figure 9. Physician's Office
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Pharmacies/Stores
 Figure 13. Global Respiratory Virus Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Respiratory Virus Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Respiratory Virus Vaccines Sales (2020-2031) & (K Units)
 Figure 16. Global Respiratory Virus Vaccines Average Price (US$/Unit) & (2020-2031)
 Figure 17. Respiratory Virus Vaccines Report Years Considered
 Figure 18. Respiratory Virus Vaccines Sales Share by Manufacturers in 2024
 Figure 19. Global Respiratory Virus Vaccines Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Respiratory Virus Vaccines Players: Market Share by Revenue in Respiratory Virus Vaccines in 2024
 Figure 21. Respiratory Virus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Respiratory Virus Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Respiratory Virus Vaccines Sales Market Share by Country (2020-2031)
 Figure 24. North America Respiratory Virus Vaccines Revenue Market Share by Country (2020-2031)
 Figure 25. United States Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Respiratory Virus Vaccines Sales Market Share by Country (2020-2031)
 Figure 28. Europe Respiratory Virus Vaccines Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Respiratory Virus Vaccines Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Respiratory Virus Vaccines Revenue Market Share by Region (2020-2031)
 Figure 36. China Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Respiratory Virus Vaccines Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Respiratory Virus Vaccines Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Respiratory Virus Vaccines Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Respiratory Virus Vaccines Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Respiratory Virus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Respiratory Virus Vaccines by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Respiratory Virus Vaccines by Type (2020-2031)
 Figure 57. Global Respiratory Virus Vaccines Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Respiratory Virus Vaccines by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Respiratory Virus Vaccines by Application (2020-2031)
 Figure 60. Global Respiratory Virus Vaccines Price (US$/Unit) by Application (2020-2031)
 Figure 61. Respiratory Virus Vaccines Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Respiratory Syncytial Virus Vaccine for Children Market Research Report 2024
Global Respiratory Syncytial Virus Vaccine for the Elderly Market Research Report 2024
Respiratory Virus Infection Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Syncytial Virus Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Viral Disease Vaccines Market Research Report 2024
Global Pneumonia Vaccine Market Insights Forecast to 2030
Global Cattle Respiratory Vaccines Market Insights Forecast to 2030
Respiratory Viruses Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Seasonal Vaccines Market Research Report 2024
COVID 19 RNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Norovirus Vaccine Market Research Report 2024
Coronavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Syncytial Virus Treatment Market Research Report 2024
RSV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prescription Respiratory Drugs Market Research Report 2024
Rabies Vaccines for Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Syncytial Virus Therapeutic Drugs Market Research Report 2024
Global Children Respiratory Syncytial Virus Therapeutics Market Research Report 2024
Global Vaccines for the Elderly Market Research Report 2024
Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions